[Skip to Content]
[Skip to Content Landing]
September 7, 1946

Current Comment

JAMA. 1946;132(1):26-27. doi:10.1001/jama.1946.02870360028010

DEMEROL  Elsewhere in this issue (page 43) appears a letter from Paul de Kruif replying to a criticism of an article on Demerol in the Reader's Digest for June made by Mr. H. J. Anslinger, Commissioner of Narcotics, in The Journal, July 13. De Kruif feels that he has been treated unfairly by Mr. Anslinger, and he quotes in his support statements by Himmelsbach, Batterman and Yonkman. Whether or not de Kruif's writing accurately reflected the views of Batterman and Yonkman, many competent authorities in the field of pharmacology question the conclusions reached by these investigators. Moreover, a letter by Dr. C. K. Himmelsbach, which appears also in this issue of The Journal (page 43), asserts that the de Kruif article has done harm and that patients with primary Demerol addiction have recently been admitted to the United States Public Health Service hospital for treatment. Finally, a supplementary statement by

First Page Preview View Large
First page PDF preview
First page PDF preview